Tower Research Capital LLC TRC Buys 2,958 Shares of Teleflex Incorporated (NYSE:TFX)

Tower Research Capital LLC TRC lifted its stake in Teleflex Incorporated (NYSE:TFX - Free Report) by 198.4% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 4,449 shares of the medical technology company's stock after acquiring an additional 2,958 shares during the period. Tower Research Capital LLC TRC's holdings in Teleflex were worth $792,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Vontobel Holding Ltd. raised its position in shares of Teleflex by 21.9% in the fourth quarter. Vontobel Holding Ltd. now owns 1,393 shares of the medical technology company's stock valued at $248,000 after purchasing an additional 250 shares during the period. JPMorgan Chase & Co. grew its stake in Teleflex by 14.3% in the 3rd quarter. JPMorgan Chase & Co. now owns 155,158 shares of the medical technology company's stock valued at $38,374,000 after buying an additional 19,466 shares during the last quarter. Sumitomo Mitsui Trust Group Inc. raised its holdings in Teleflex by 5.2% in the 4th quarter. Sumitomo Mitsui Trust Group Inc. now owns 108,231 shares of the medical technology company's stock worth $19,263,000 after acquiring an additional 5,322 shares during the period. Lecap Asset Management Ltd. bought a new position in Teleflex in the 4th quarter worth $729,000. Finally, Mirae Asset Global Investments Co. Ltd. lifted its position in Teleflex by 35.1% during the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 5,875 shares of the medical technology company's stock worth $1,053,000 after acquiring an additional 1,527 shares during the last quarter. 95.62% of the stock is currently owned by institutional investors and hedge funds.

Teleflex Trading Down 0.4 %

Shares of TFX stock opened at $135.08 on Friday. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.39 and a current ratio of 2.42. The firm has a fifty day moving average of $140.16 and a 200-day moving average of $173.91. Teleflex Incorporated has a 52-week low of $124.66 and a 52-week high of $249.91. The stock has a market cap of $6.26 billion, a price-to-earnings ratio of 26.85, a P/E/G ratio of 1.73 and a beta of 1.19.

Teleflex (NYSE:TFX - Get Free Report) last posted its quarterly earnings results on Thursday, February 27th. The medical technology company reported $3.89 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.86 by $0.03. The firm had revenue of $795.40 million during the quarter, compared to analyst estimates of $813.24 million. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. On average, equities research analysts forecast that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.

Teleflex Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, March 17th. Shareholders of record on Friday, March 7th were given a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a yield of 1.01%. The ex-dividend date of this dividend was Friday, March 7th. Teleflex's dividend payout ratio (DPR) is 95.77%.

Analysts Set New Price Targets

A number of equities analysts have recently commented on the company. Piper Sandler reiterated a "neutral" rating and issued a $140.00 price objective (down from $255.00) on shares of Teleflex in a research note on Friday, February 28th. Needham & Company LLC reaffirmed a "hold" rating on shares of Teleflex in a research report on Wednesday, March 12th. Wells Fargo & Company reduced their price objective on Teleflex from $214.00 to $146.00 and set an "equal weight" rating for the company in a research report on Friday, February 28th. Morgan Stanley dropped their target price on shares of Teleflex from $275.00 to $191.00 and set an "overweight" rating on the stock in a research report on Wednesday, March 5th. Finally, Bank of America downgraded shares of Teleflex from a "neutral" rating to an "underperform" rating and reduced their price target for the company from $235.00 to $140.00 in a report on Tuesday, March 4th. One analyst has rated the stock with a sell rating, nine have assigned a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat, Teleflex currently has an average rating of "Hold" and an average target price of $169.63.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.

Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.